Resource impact statement

No significant resource impact is anticipated

We do not expect this guidance to have a significant impact on resources; that is, it will be less than £1 million per year in England (or £1,800 per 100,000 population). Where practice changes as a result of implementing the recommendations the additional cost of Peristeen is expected to be offset by reductions in adverse events.

This technology is commissioned by clinical commissioning groups. Providers are NHS hospital trusts, community providers and primary care providers.

This page was last updated: